8-K
filed May 16, 2024, 7:59 PM ET
ticker REVB
CIK 0001810560
other material
confidence high
sentiment neutral
materiality 0.15
Revelation Bio shareholders approve director elections, equity plan increase, auditor ratification
REVELATION BIOSCIENCES, INC.
- James Rolke (122,822 for) and Jess Roper (122,543 for) elected as Class B directors; 461,538 broker non-votes.
- Approved amendment to 2021 Equity Incentive Plan increasing reserved shares from 21,623 to 163,294 (107,447 for, 42,981 against).
- Ratified Baker Tilly US, LLP as auditor for FY2024 with 595,879 for, 18,558 against.
- Quorum achieved with 614,695 shares present (greater than 1/3 of 1,632,935 outstanding shares).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
REVELATION BIOSCIENCES, INC. shareholders approved Approval to increase the number of shares reserved under the Company's 2021 Equity Incentive Plan from 21,623 to 163,294.
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
Stockholders approved an amendment to the 2021 Equity Incentive Plan to increase the number of shares reserved under the 2021 Equity Incentive Plan from 21,623 to 163,294, based on the votes listed below: For Against Abstain 107,447 42,981 2,729 There were 461,538 broker non-votes regarding this proposal.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
REVELATION BIOSCIENCES, INC. shareholders approved Ratification of Baker Tilly US, LLP as auditor for fiscal year ending December 31, 2024 at the 2024-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-12-31
Exact text from the filing
Stockholders ratified Baker Tilly US, LLP to audit our financial statements for the fiscal year ending December 31, 2024, based on the votes listed below: For Against Abstain 595,879 18,558 258 There were no broker non-votes regarding this proposal.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
REVELATION BIOSCIENCES, INC. shareholders approved Election of two nominees for Class B director: James Rolke and Jess Roper.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
Stockholders approved to elect the two nominees for Class B director named herein to serve until the 2027 Annual Meeting or their successors are duly elected and qualified, based on the votes listed below: Director Nominee For Against Abstain James Rolke 122,822 23,715 6,620 Jess Roper 122,543 27,978 2,636 There were 461,538 broker non-votes regarding the election of directors.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.